At a glance
- Originator Aventis
- Class Antiallergics; Antiasthmatics; Piperidines; Pyrrolidines
- Mechanism of Action Neurokinin 1 antagonists; Neurokinin 2 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 06 Jun 1997 Discontinued-Preclinical for Asthma in USA (Unknown route)
- 08 Aug 1996 Preclinical development for Asthma in USA (Unknown route)